Clinical Trial Update: A Phase 1 Study in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by Eli Lilly in participants with advanced cancer, including anal squamous cell carcinoma, head and neck squamous cell carcinoma, lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Squamous Cell Carcinoma
• Head and Neck Squamous Cell Carcinoma
• Lung Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Advanced Cancer, Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED